English: Look, we had a review at the start of this Assembly term because of issues that Members around the Chamber have raised about the apparent inequalities in access, and people's inability to understand the system. And, to be fair, the system wasn't an easy one to understand for clinicians or indeed for members of the public. Following the review, we've implemented all of the 27 recommendations that came up, and it's very clear now the clinician has to support the individual patient funding request to go to a review. Now, I can't comment on the individual circumstance that the Member is directly engaged with. Across the system, more than seven in 10 applications for medicines under the IPFR process are agreed. I think it would be helpful if we had yet another conversation with you about what's happened in this case and about how the health board's IPFR process does and doesn't work, and about the level of clarity in the explanation provided by both the health board and the clinician about any reasons for refusal and why that is. The awful truth is, from a whole-system point of view, you understand there will be times when there is a refusal to provide a treatment on the national health service. It is always a much more difficult matter to be the individual, to be told by one person in our healthcare system, 'I think this is what you need', and to be told overall by the system, 'You still can't have it'. I'm happy to sit down to try and understand what that looks like with your constituent, but I really think we need to go back to the clinicians making choices together with the health board, and have real clarity in the decision-making process.
Welsh: Edrychwch, cawsom adolygiad ar ddechrau tymor y Cynulliad hwn oherwydd materion y mae Aelodau o bob rhan o'r Siambr wedi'u codi ynghylch yr anghydraddoldebau amlwg o ran mynediad, ac anallu pobl i ddeall y system. Ac a bod yn deg, nid oedd y system yn un hawdd i glinigwyr nac yn wir aelodau'r cyhoedd ei deall. Yn dilyn yr adolygiad, rydym wedi gweithredu pob un o'r 27 argymhelliad a nodwyd, ac mae'n amlwg iawn bellach fod yn rhaid i'r clinigydd gefnogi cais cyllido'r claf unigol er mwyn cael adolygiad. Nawr, ni allaf wneud sylwadau ar yr amgylchiadau unigol y sonia'r Aelod amdanynt. Ar draws y system, mae mwy na saith cais o bob 10 am feddyginiaethau o dan broses y ceisiadau cyllido cleifion unigol yn cael eu derbyn. Credaf y byddai'n ddefnyddiol pe baem yn cael sgwrs arall gyda chi ynglŷn â'r hyn sydd wedi digwydd yn yr achos hwn ac ynglŷn â sut y mae proses ceisiadau cyllido cleifion unigol y bwrdd iechyd yn gweithio a ddim yn gweithio, ac ynglŷn â lefel yr eglurder o ran yr esboniad a ddarperir gan y bwrdd iechyd a'r clinigydd ynghylch unrhyw resymau dros wrthod a pham. Y gwir ofnadwy amdani yw, o safbwynt system gyfan, rydych yn deall y bydd yna adegau pan fydd y gwasanaeth iechyd gwladol yn gwrthod darparu triniaeth. Mae bob amser yn fater llawer anos i'r unigolyn sy'n cael gwybod gan un unigolyn yn ein system gofal iechyd, 'Rwy'n credu mai dyma sydd ei angen arnoch', a chael gwybod gan y system yn gyffredinol, 'Ni allwch ei gael'. Rwy'n fwy na pharod i geisio deall beth yw hynny gyda'ch etholwr, ond rwy'n credu o ddifrif fod angen i ni ddychwelyd at glinigwyr yn gwneud dewisiadau ar y cyd â'r bwrdd iechyd, a chael eglurder gwirioneddol yn y broses o wneud penderfyniadau.